Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin

Author： Thrasher James   Daniels Kristen   Patel Sanjay   Whetteckey Jacqueline  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.17, 2012-12, pp. : 2443-2452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.  

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

Linagliptin: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Deeks Emma D.  

Drugs, Vol. 72, Iss. 13, 2012-09 ,pp. : 1793-1824

Adis International

Access to resources Recommend Favorite

Linagliptin: a guide to its use in type 2 diabetes mellitus

By Scott Lesley J.   Lyseng-Williamson Katherine A.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 5, 2012-05 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Multicentre, Double-blind, Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in China

By Gao X    

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 812-821

Field House Publishing

Access to resources Recommend Favorite

Linagliptin for the treatment of type 2 diabetes

By Del Prato Stefano  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2759-2762

Informa Healthcare

Access to resources Recommend Favorite